DocDollars

Novartis Pharma AG

Switzerland · Reporting entity ID 100000000058

Total reported 2019–2025
$14.4M
#400 of 2,960 reporting companies — 0% of all reported industry payments
$4.58M in general payments across 1,708 records, plus $9.81M in research funding across 1,353 records.

How it breaks down

General payments $4,581,816
Research funding $9,813,508

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Novartis Pharma AG reported $14.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #400 of 2,960 reporting companies. 68% of that was research funding and 32% general payments such as consulting, speaking, food and travel. 1,708 general payment records and 1,353 research records were filed.

Common questions about Novartis Pharma AG

How much has Novartis Pharma AG paid US doctors?

Novartis Pharma AG reported $14,395,324 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,581,816 in general payments, $9,813,508 in research funding.

How does Novartis Pharma AG rank among drug and device companies?

It ranks #400 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Novartis Pharma AG mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.